A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways

GV1001, a human telomerase reverse transcriptase catalytic subunit-derived 16-mer peptide, has been developed as a novel anticancer vaccine against various cancers including pancreatic cancer. In the current study, we demonstrate the regulatory roles and mechanisms of GV1001 in endothelial cell resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae Hyeon, Cho, Young-Rak, Ahn, Eun-Kyung, Kim, Sunho, Han, Surim, Kim, Sung Joon, Bae, Gyu-Un, Oh, Joa Sub, Seo, Dong-Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526227/
https://www.ncbi.nlm.nih.gov/pubmed/36183673
http://dx.doi.org/10.1016/j.tranon.2022.101546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526227/
https://www.ncbi.nlm.nih.gov/pubmed/36183673
http://dx.doi.org/10.1016/j.tranon.2022.101546

Ejemplares similares